We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Philips Healthcare

Operates in Diagnostic Imaging Systems, Patient Care and Clinical Informatics, Customer Services, and Home Healthcare... read more Featured Products: More products

Download Mobile App




Clinical Trials Show Benefits of iFR Compared to FFR

By MedImaging International staff writers
Posted on 29 Mar 2017
Print article
Image: Clinicians using the innovative instant wave-Free Ratio (iFR) technique (Photo courtesy of Philips Healthcare).
Image: Clinicians using the innovative instant wave-Free Ratio (iFR) technique (Photo courtesy of Philips Healthcare).
Results from several studies indicate that the adoption of instant wave-Free Ratio (iFR) instead of Fractional Flow Reserve (FFR) for the assessment of Coronary Artery Disease (CAD) is a more cost-effective, and faster diagnostic solution.

The two clinical trials were the largest randomized coronary physiology outcome studies that have been carried out to date, and included 4,529 patients. The two trials also showed that iFR could nearly eliminate severe patient symptoms completely, compared to FFR.

The results of the two large trials, that took place in 49 centers in Europe, Africa, Asia, and North America were announced by Royal Philips and were published in the New England Journal of Medicine. The iFR index was developed by Philips, to enable hyperemia-free physiological assessment of blockages in coronary arteries.

Business Leader at Philips Volcano, Christopher Barys, said, “The clinical validation of our innovations is a critical element of our strategy in image-guided therapy. The outcomes of these clinical studies underpin the value of iFR and its benefits for patient safety and effective diagnoses. It is our hope that the results advance the adoption of iFR to help physicians improve patient care. This is one of the largest coronary physiologic datasets ever collected and truly demonstrates the value of iFR in the physiological assessment of coronary artery disease in patients.”

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Ultrasound System
P25 Elite
Under Table Shield
3 Section Double Pivot Under Table Shield
New
Oncology Information System
RayCare

Print article

Channels

Ultrasound

view channel
Image: Structure of the proposed transparent ultrasound transducer and its optical transmittance (Photo courtesy of POSTECH)

Ultrasensitive Broadband Transparent Ultrasound Transducer Enhances Medical Diagnosis

The ultrasound-photoacoustic dual-modal imaging system combines molecular imaging contrast with ultrasound imaging. It can display molecular and structural details inside the body in real time without... Read more

Nuclear Medicine

view channel
Image: PET/CT of a 60-year-old male patient with clinical suspicion of lung cancer (Photo courtesy of EJNMMI Physics)

Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times

F-18 FDG-PET scans are a way to look inside the body using a special dye, and these scans can be either static or dynamic. Static scans happen 60 minutes after the dye is administered into the body, showing... Read more

Industry News

view channel
Image: The acquisition will expand IBA’s medical imaging quality assurance offering (Photo courtesy of Radcal)

IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering

Ion Beam Applications S.A. (IBA, Louvain-La-Neuve, Belgium), the global leader in particle accelerator technology and a world-leading provider of dosimetry and quality assurance (QA) solutions, has entered... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.